Search results for:
durvalumab
durvalumab
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Durvalumab |
SOLUTION, INTRAVENOUS |
50 mg/mL (2.4 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Durvalumab |
SOLUTION, INTRAVENOUS |
50 mg/mL (10 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Jul. 18, 2023
UNC Health
System Formulary Restriction:
Use of durvalumab injection (Imfinzi) is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions